GENE Therapy Payment Act
Kurt Schrader introduced the bipartisan GENE Therapy Payment Act. This legislation will help those with life-threatening illnesses who can benefit from gene-therapy treatments. These treatments can be incredibly expensive, and this legislation will allow for a new value-based payment system so that Medicaid beneficiaries can receive these innovative treatments.
“The GENE Therapy Payment Act will allow for value-based payments in Medicaid so that more Americans can benefit from potentially curative and groundbreaking gene therapies,” said Rep. Schrader. "This is commonsense, bipartisan legislation that will help everyday Americans access the care that they need, without bankrupting state Medicaid programs, allowing for shared risk that will reward the companies working to advance these extremely expensive treatments, when and only when they obtain anticipated outcomes.”
Tags: Health Care